ReviewFrontiers in immunology2020

Systemic CD4 Immunity as a Key Contributor to PD-L1/PD-1 Blockade Immunotherapy Efficacy.

Miren Zuazo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.